MENU
GALT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Galectin Therapeutics (GALT) Earnings Date & Reports
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
GALT is expected to report earnings to fall 12.50% to -7 cents per share on August 17
Q2'26
Est.
$-0.07
Q4'25
Beat
by $0.02
Q3'25
Beat
by $0.05
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.05
The last earnings report on March 31 showed earnings per share of -7 cents, beating the estimate of -10 cents. With 2.04M shares outstanding, the current market capitalization sits at 184.40M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of drugs to combat various diseases
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
4960 Peachtree Industrial Boulevard
Phone
+1 678 620-3186
Employees
9
Web
https://www.galectintherapeutics.com